Yang, Xinning
447  Ergebnisse:
Personensuche X
?
2

Statin Drug‐Drug Interactions: Pharmacokinetic Basis of FDA..:

Mease, James ; Ramamoorthy, Anuradha ; Yang, Xinning...
The Journal of Clinical Pharmacology.  64 (2024)  6 - p. 704-712 , 2024
 
?
3

Clinical studies on pharmacogenomics and DDIS involving dru..:

Yang, Xinning
Drug Metabolism and Pharmacokinetics.  55 (2024)  - p. 100557 , 2024
 
?
4

Clinical Implications of Altered Drug Transporter Abundance..:

Chu, Xiaoyan ; Prasad, Bhagwat ; Neuhoff, Sibylle...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 501-526 , 2022
 
?
5

Clinical pharmacology information in regulatory submissions..:

Hsieh, Julie ; Sahre, Martina ; Yang, Xinning..
Clinical and Translational Science.  15 (2022)  11 - p. 2583-2596 , 2022
 
?
6

Using Endogenous Biomarkers to Derisk Assessment of Transpo..:

Arya, Vikram ; Reynolds, Kellie S. ; Yang, Xinning
The Journal of Clinical Pharmacology.  62 (2022)  12 - p. 1501-1506 , 2022
 
?
7

Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibitio..:

Taskar, Kunal S. ; Yang, Xinning ; Neuhoff, Sibylle...
Clinical Pharmacology & Therapeutics.  112 (2022)  3 - p. 573-592 , 2022
 
?
 
?
10

Do Inhibitory Metabolites Impact DDI Risk Assessment? Analy..:

Steinbronn, Claire ; Yang, Xinning ; Yu, Jingjing...
Clinical Pharmacology & Therapeutics.  110 (2021)  2 - p. 452-463 , 2021
 
?
 
?
13

A12 - Mechanistic kidney models for creatinine: Relevance o..:

Scotcher, Daniel ; Arya, Vikram ; Yang, Xinning...
Drug Metabolism and Pharmacokinetics.  35 (2020)  1 - p. S22 , 2020
 
?
 
1-15